SCHEMBL17852133

SCHEMBL17852133

CC(C)(O)c1ccc(Br)cc1-c1cc2ccccc2c2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
TRPM4 Q8TD43 1/20 0.37
CYP11B1 P15538 1/20 0.36
CYP2A6 P11509 1/20 0.35
ALDH1A1 P00352 4/20 0.34
HPGD P15428 3/20 0.34
HIF1A Q16665 2/20 0.34
HSD17B10 Q99714 2/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
CASP1 P29466 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KCNJ11 Q14654 2/20 0.33
CYP1B1 Q16678 1/20 0.32
NISCH Q9Y2I1 1/20 0.32
MAPT P10636 2/20 0.32
POLB P06746 1/20 0.32
PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21102404 0.85 ALDH1A1 (0.39) MEN1KMT2ARXFP1TRPM4CYP11B1
SCHEMBL17836992 0.85 KCNJ11 (0.38) MEN1KMT2ARXFP1CYP2A6ALDH1A1
SCHEMBL15450042 0.82 ALDH1A1 (0.43) MEN1KMT2ATRPM4CYP11B1ALDH1A1
SCHEMBL17841053 0.82 TRPM4 (0.42) MEN1KMT2ATRPM4CYP11B1CYP2A6
SCHEMBL19110411 0.76 NMUR2 (0.39) L3MBTL1
SCHEMBL17852129 0.76 CYP2A6 (0.47) CYP11B1CYP2A6
SCHEMBL25905117 0.76 TRPM4 (0.52) MEN1KMT2ARXFP1TRPM4CYP11B1
SCHEMBL16585739 0.76 PTGDR2 (0.43) ALDH1A1HPGDTSHRMAPK1MAPT
SCHEMBL16340777 0.75 HPRT1 (0.39) MEN1KMT2ARXFP1CYP2A6ALDH1A1
SCHEMBL17841035 0.75 ALDH1A1 (0.42) MEN1KMT2ATRPM4CYP11B1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME L1CAM, H1-10, H1-0 MEN1 1272/4885KMT2A 2098/4885RXFP1 394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.